Goldman Sachs Maintains Buy on Tenet Healthcare, Raises Price Target to $173
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Jamie Perse maintains a Buy rating on Tenet Healthcare (NYSE:THC) and raises the price target from $156 to $173.
July 30, 2024 | 1:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Goldman Sachs analyst Jamie Perse maintains a Buy rating on Tenet Healthcare and raises the price target from $156 to $173.
The Buy rating and increased price target from a reputable analyst at Goldman Sachs is likely to positively impact Tenet Healthcare's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100